Revised US HIV treatment guidelines call for a return to "hit hard, hit early"
This article was originally published in Scrip
Executive Summary
A panel of experts from the US Department of Health and Human Services (DHHS) has released revised guidelines recommending that people with HIV start antiretroviral therapy (ART) at CD4 cell counts between 350 and 500 cells/mm3, with some even recommending treatment for patients with CD4 counts greater than 500 cells/mm3. AIDS groups welcomed the change, touting it as a shift back toward the "hit hard, hit early" ART approach that prevailed in the late 1990s.